Literature DB >> 637076

Endogenous levels of prostaglandin F2alpha and its main metabolites in plasma and endometrium of normal and dysmenorrheic women.

V Lundström, K Gréen.   

Abstract

The concentrations of prostaglandin F2alpha 15-keto-13, 14-dihydro-PGF2alpha, and 13,14-dihydro-PGF2alpha were determined in plasma and in endometrial specimens taken from both dysmenorrheic and normal women at the time of their menstruation. The estimations were carried out by means of the gas chromatography-mass spectrometry method. The plasma levels of 15-keto-13,14-dihydro-PGF2alpha in dysmenorrheic women ranged between 32 and 105 pg. per milliliter, which are significantly higher than the corresponding levels in eumenorrheic women, 20 to 33 pg. per milliliter. On the first day of menstrual bleeding the concentration of PGF2alpha in the endometrium was approximately 4 times higher (300 to 2,600 pg. per milligram) in cases of dysmenorrhea than in normal subjects. Treatment with either oral contraceptives or prostaglandin synthetase inhibitors lowered the concentrations significantly and the majority of patients became symptom free.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 637076     DOI: 10.1016/0002-9378(78)90320-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  30 in total

1.  Stress and dysmenorrhoea: a population based prospective study.

Authors:  L Wang; X Wang; W Wang; C Chen; A G Ronnennberg; W Guang; A Huang; Z Fang; T Zang; L Wang; X Xu
Journal:  Occup Environ Med       Date:  2004-12       Impact factor: 4.402

2.  Prostaglandin inhibitors: rational therapy for dysmenorrhea.

Authors:  J Sorbie
Journal:  Can Fam Physician       Date:  1982-01       Impact factor: 3.275

Review 3.  Treatment of dysmenorrhoea and premenstrual syndrome with non-steroidal anti-inflammatory drugs.

Authors:  S S Shapiro
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

4.  An ROC analysis of pain reactions in dysmenorrheic and nondysmenorrheic women.

Authors:  P Goolkasian
Journal:  Percept Psychophys       Date:  1983-10

5.  Cyclic changes in pain perception: an ROC analysis.

Authors:  P Goolkasian
Journal:  Percept Psychophys       Date:  1980-06

6.  Menstrual pain and epithelial ovarian cancer risk.

Authors:  Ana Babic; Daniel W Cramer; Linda J Titus; Shelley S Tworoger; Kathryn L Terry
Journal:  Cancer Causes Control       Date:  2014-09-05       Impact factor: 2.506

7.  Measuring menstrual discomfort: a comparison of interview and diary data.

Authors:  Anne Marie Zaura Jukic; Clarice R Weinberg; Donna D Baird; Paige P Hornsby; Allen J Wilcox
Journal:  Epidemiology       Date:  2008-11       Impact factor: 4.822

Review 8.  Exercise and primary dysmenorrhoea : a comprehensive and critical review of the literature.

Authors:  Amanda J Daley
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

9.  The Menstrual Symptom Questionnaire and spasmodic/congestive dysmenorrhea: measurement of an invalid construct.

Authors:  S K Webster; H J Martin; D Uchalik; L Gannon
Journal:  J Behav Med       Date:  1979-03

Review 10.  Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations.

Authors:  M Y Dawood
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.